Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thyroid Neoplasms | 16 | 2024 | 2332 | 2.510 |
Why?
|
Iodine Radioisotopes | 5 | 2021 | 1033 | 1.820 |
Why?
|
Carcinoma, Papillary | 3 | 2023 | 784 | 1.020 |
Why?
|
Adenocarcinoma, Follicular | 3 | 2021 | 323 | 0.940 |
Why?
|
Mitotane | 1 | 2019 | 20 | 0.670 |
Why?
|
Mitochondrial Proton-Translocating ATPases | 1 | 2019 | 53 | 0.650 |
Why?
|
Public Facilities | 1 | 2018 | 35 | 0.630 |
Why?
|
Carcinoma | 2 | 2023 | 2328 | 0.610 |
Why?
|
Security Measures | 1 | 2018 | 82 | 0.610 |
Why?
|
Metformin | 2 | 2015 | 907 | 0.590 |
Why?
|
Thyroid Nodule | 4 | 2024 | 764 | 0.530 |
Why?
|
Radiation-Protective Agents | 1 | 2015 | 88 | 0.510 |
Why?
|
Documentation | 1 | 2018 | 897 | 0.400 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2019 | 1519 | 0.360 |
Why?
|
Pyrroles | 1 | 2015 | 1126 | 0.330 |
Why?
|
Radiotherapy | 1 | 2015 | 1499 | 0.320 |
Why?
|
Indoles | 1 | 2015 | 1832 | 0.290 |
Why?
|
Hematopoiesis | 1 | 2016 | 2049 | 0.270 |
Why?
|
Membrane Potential, Mitochondrial | 2 | 2019 | 293 | 0.270 |
Why?
|
Adenocarcinoma | 1 | 2023 | 6332 | 0.260 |
Why?
|
Glucose | 1 | 2015 | 4345 | 0.220 |
Why?
|
Bone Neoplasms | 1 | 2015 | 2527 | 0.220 |
Why?
|
Physicians | 1 | 2018 | 4591 | 0.180 |
Why?
|
Watchful Waiting | 1 | 2024 | 491 | 0.170 |
Why?
|
Thyroxine | 2 | 2022 | 668 | 0.160 |
Why?
|
Biopsy, Fine-Needle | 4 | 2024 | 1118 | 0.150 |
Why?
|
Nelfinavir | 1 | 2017 | 68 | 0.140 |
Why?
|
Hypothyroidism | 1 | 2022 | 667 | 0.140 |
Why?
|
Antineoplastic Agents | 2 | 2017 | 13635 | 0.130 |
Why?
|
Erythrocyte Count | 1 | 2015 | 157 | 0.130 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2023 | 2052 | 0.130 |
Why?
|
Leukopenia | 1 | 2015 | 213 | 0.120 |
Why?
|
Thyrotropin | 1 | 2019 | 835 | 0.120 |
Why?
|
Blood Platelets | 2 | 2016 | 2481 | 0.120 |
Why?
|
Deoxyglucose | 1 | 2015 | 333 | 0.120 |
Why?
|
Adenoma, Oxyphilic | 1 | 2015 | 148 | 0.120 |
Why?
|
Prognosis | 3 | 2023 | 29588 | 0.110 |
Why?
|
Retrospective Studies | 10 | 2024 | 80575 | 0.110 |
Why?
|
Culture Media | 1 | 2015 | 899 | 0.110 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2015 | 716 | 0.110 |
Why?
|
Nausea | 1 | 2015 | 679 | 0.100 |
Why?
|
Thyroid Hormones | 1 | 2015 | 404 | 0.100 |
Why?
|
Caspases | 1 | 2015 | 877 | 0.100 |
Why?
|
Cell Line, Tumor | 3 | 2019 | 16966 | 0.100 |
Why?
|
DNA Damage | 2 | 2019 | 2442 | 0.100 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2015 | 598 | 0.100 |
Why?
|
Leukocyte Count | 1 | 2015 | 1597 | 0.100 |
Why?
|
Heat-Shock Proteins | 1 | 2015 | 796 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2019 | 8527 | 0.090 |
Why?
|
Glycolysis | 1 | 2015 | 836 | 0.090 |
Why?
|
Drug Synergism | 1 | 2015 | 1757 | 0.090 |
Why?
|
Lung Neoplasms | 1 | 2015 | 13333 | 0.090 |
Why?
|
Thyroidectomy | 1 | 2015 | 907 | 0.090 |
Why?
|
Hemoglobins | 1 | 2015 | 1524 | 0.080 |
Why?
|
Enzyme Activation | 1 | 2015 | 3592 | 0.080 |
Why?
|
Endoplasmic Reticulum | 1 | 2015 | 1133 | 0.080 |
Why?
|
Disease-Free Survival | 2 | 2019 | 6815 | 0.080 |
Why?
|
Cell Survival | 1 | 2019 | 5792 | 0.080 |
Why?
|
Diarrhea | 1 | 2015 | 1319 | 0.080 |
Why?
|
Fatigue | 1 | 2015 | 1551 | 0.080 |
Why?
|
Humans | 17 | 2024 | 761326 | 0.080 |
Why?
|
Bone Marrow Cells | 1 | 2015 | 2416 | 0.080 |
Why?
|
Cell Division | 1 | 2015 | 4466 | 0.070 |
Why?
|
Leukocytes | 1 | 2016 | 2029 | 0.070 |
Why?
|
Protein Processing, Post-Translational | 1 | 2015 | 1974 | 0.070 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3512 | 0.070 |
Why?
|
Cell Proliferation | 2 | 2019 | 10431 | 0.070 |
Why?
|
Ultrasonography | 3 | 2024 | 5970 | 0.060 |
Why?
|
Aged | 8 | 2024 | 169179 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2021 | 58946 | 0.060 |
Why?
|
Phosphorylation | 1 | 2015 | 8312 | 0.060 |
Why?
|
Middle Aged | 8 | 2024 | 220774 | 0.060 |
Why?
|
Adult | 8 | 2024 | 221122 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2811 | 0.060 |
Why?
|
Gene Expression Profiling | 2 | 2021 | 9414 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2015 | 3611 | 0.050 |
Why?
|
Hypoglycemic Agents | 1 | 2015 | 3082 | 0.050 |
Why?
|
Apoptosis | 2 | 2017 | 9474 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2015 | 4936 | 0.050 |
Why?
|
Male | 9 | 2024 | 360621 | 0.050 |
Why?
|
Thyroid Function Tests | 1 | 2022 | 289 | 0.050 |
Why?
|
Positron-Emission Tomography | 1 | 2016 | 6478 | 0.040 |
Why?
|
Female | 8 | 2024 | 392485 | 0.040 |
Why?
|
Mutation | 1 | 2023 | 30044 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2015 | 7852 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20092 | 0.040 |
Why?
|
Thyroglobulin | 1 | 2016 | 111 | 0.030 |
Why?
|
Whole Body Imaging | 1 | 2016 | 283 | 0.030 |
Why?
|
HIV Protease Inhibitors | 1 | 2017 | 432 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 614 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2024 | 5247 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2024 | 39108 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2024 | 14665 | 0.020 |
Why?
|
Young Adult | 1 | 2016 | 59196 | 0.020 |
Why?
|
Genomics | 1 | 2024 | 5817 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3638 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2024 | 15262 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2017 | 2453 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2016 | 2009 | 0.020 |
Why?
|
Child | 1 | 2016 | 80156 | 0.020 |
Why?
|
Adolescent | 1 | 2016 | 88305 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2016 | 2650 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4649 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2024 | 9275 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2016 | 4908 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2017 | 3448 | 0.020 |
Why?
|
Cell Movement | 1 | 2017 | 5202 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8632 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26108 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13500 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 54405 | 0.010 |
Why?
|
Concepts
(111)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_